Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase
inhibitor of the meta-disulfamoylbenzene class.
Physician reviewed dichlorphenamide patient information - includes
dichlorphenamide description, dosage and directions.
Medscape - Periodic paralysis indication dosing for Keveyis (dichlorphenamide),
frequency-based adverse effects, comprehensive interactions, ...
Dec 1, 2015 ... Dichlorphenamide is used to treat inherited muscle disorders, such as primary
hyperkalemic periodic paralysis, primary hypokalemic periodic ...
Jun 11, 2012 ... These highlights do not include all the information needed to use DARANIDE - ®
(dichlorphenamide tablets USP) safely and effectively.
dichlorphenamide | C6H6Cl2N2O4S2 | CID 3038 - structure, chemical names,
physical and chemical properties, classification, patents, literature, biological ...
KEVEYISTM (dichlorphenamide) tablets, for oral use. Initial U.S. Approval: ...
Hypersensitivity to dichlorphenamide or other sulfonamides (4). • Concomitant
Find patient medical information for dichlorphenamide oral on WebMD including
its uses, side effects and safety, interactions, pictures, warnings and user ...
Oct 14, 2011 ... A phase 3 trial of the drug dichlorphenamide in hyperkalemic and hypokalemic
periodic paralysis is open at several U.S. and European centers.
Apr 11, 2016 ... Dichlorphenamide (Keveyis – Taro), an oral carbonic anhydrase inhibitor, has
been approved by the FDA for treatment of primary hypokalemic ...